- Business Model
- B2B
- Website
- enarabio.com
About
Developing therapies targeting Dark Antigens for cancer
Summary
Enara Bio is a Biotech company.
Similar Companies
BeiGeneIPO
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...
Cambridge, United States10001+Biotech, Oncology
Corporate Round·$2.8B·Jan 2020
Avenzo
Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...
San Diego, United States1–10Biotech, Oncology
Series B·$832.0M·Sep 2025
ParexelAcquired
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Raleigh, United States10001+Biotech
Private Equity·$5.0B·Jun 2017
Simtra BioPharma Solutions
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Bloomington, United States1001–5000Biotech, Contract Manufacturing
Private Equity·$4.3B·Oct 2023
Pharmaceutical Product Development, Inc. (PPD)Acquired
Global contract research organization providing comprehensive drug development and laboratory ser...
Wilmington, United States10001+Biotech, Healthcare
Private Equity·$3.9B·Jan 2019
IVI-RMA
Global fertility clinics platform
Valencia, Spain5001–10000Biotech, Healthcare
Private Equity·$3.3B·Apr 2022